Trial Profile
A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With EpiDuo Forte Gel (0.3% Adapalene/ 2.5% BPO) in Subjects With Acne Vulgaris Under Maximal Use Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2019
Price :
$35
*
At a glance
- Drugs Adapalene/benzoyl peroxide/clindamycin phosphate (Primary) ; Adapalene/benzoyl peroxide
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Bausch Health Companies
- 18 Oct 2019 Status changed from recruiting to completed.
- 07 Sep 2018 New trial record